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WITHOUT CLEAR RULES, PTAB PRACTICES MAY RUN 
AFOUL OF THE APA 
ARPITA BHATTACHARYYA & RACHEL L. EMSLEY* 
INTRODUCTION 
Like all administrative agencies of the United States, the internal pro-
cedures of the United States Patent and Trademark Office (USPTO) and its 
judicial arm—the Patent Trial and Appeal Board (PTAB)—are governed by 
the Administrative Procedure Act (APA).1 The APA imposes procedural 
requirements for all formal adjudications before the PTAB, including inter 
partes review (IPR), post-grant review (PGR), and Covered Business 
Method review (CBM).2 Under the APA, each interested party is entitled 
to receive a timely notice of “the matters of fact and law asserted,” an op-
portunity to submit and consider facts and arguments, and “to submit rebuttal 
evidence . . . as may be required for a full and true disclosure of the facts.”3 
The Federal Circuit has explained that the APA imposes limits on the 
PTAB’s actions and procedures, and that the PTAB may not “change theo-
ries in midstream” without giving the adversely affected party reasonable 
notice of the change and the opportunity to respond under the new theory.4 
The codified rules for PTAB procedure—the American Invents Act 
(AIA) Statute and USPTO Trial Practice Regulations5—do not themselves 
ensure APA compliance. In other words, simply following these rules does 
not guarantee that the proceeding will meet the APA’s notice and oppor-
tunity to respond requirements. Instead, as explained below, parties must be 
vigilant and take measures to establish a favorable record for appeal, i.e., 
one that establishes the APA violation or that protects against such a 
claim. This article explores one area that has emerged as a fertile ground 
 
 Arpita Bhattacharyya, Ph.D. is an associate in the Palo Alto office and Rachel L. Emsley is an associate 
in the Boston office of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. The authors extend their 
gratitude to Joshua Goldberg, partner in the DC office of Finnegan, for his guidance in drafting this article. 
 1.  Dell Inc. v. Acceleron, LLC, 818 F.3d 1293, 1298 (Fed. Cir. 2016); see also SAS Inst., Inc. 
v. ComplementSoft, LLC., 825 F.3d 1341, 1351 (Fed. Cir. 2016). 
 2.  See 5 U.S.C. §§ 551–559 (2012); see also Dell, 818 F.3d at 1301. 
 3.  Dell, 818 F.3d at 1301; see also Belden Inc. v. Berk-Tek LLC., 805 F.3d 1064, 1080 (Fed. 
Cir. 2015); 5 U.S.C. §§ 554(b)–(c), 556(d) (2012). 
 4.  Belden, 805 F.3d at 1080. 
 5.  See America Invents Act, 35 U.S.C. §§ 311–29 (2012); see also 37 C.F.R. § 42 (2017). 
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for APA issues: when a party presents “new argument” late in the pro-
ceeding but the PTAB’s rules do not provide a clear path for the opposing 
party to respond. 
This Article begins with a review of the PTAB procedures for presen-
tation of arguments and evidence in Part I. Part II explores the contours of 
APA violations as established by the Federal Circuit thus far. Finally, in Part 
III, this Article discusses the evolving PTAB practice for handling new ar-
guments and proposes best practices for avoiding or establishing APA issues 
on appeal. 
I. PTAB PRACTICE 
PTAB rules and procedures, and ultimately the Congressional mandate 
to conclude review in one year from institution,6 limit the parties’ ability to 
present evidence and argument.7 The petitioner bears the burden in the initial 
filing to submit, up front, the evidence and arguments it will rely upon in a 
14,000 words IPR petition or 18,700 words PGR/CBM petition.8 If the 
PTAB institutes a trial, the patent owner submits a substantive response in 
14,000 words (for IPR) or 18,700 words (for PGR/CBM), and the petitioner 
is allowed a single, shorter reply (5,600 words for IPR, PGR, and CBM) to 
the patent owner’s arguments.9 The rules provide no further right to substan-
 
 6.  35 U.S.C. § 316(a)(11) (2012) (“requiring that the final determination in an inter partes 
review be issued not later than 1 year after the date on which the Director notices the institution of a 
review under this chapter, except that the Director may, for good cause shown, extend the 1-year 
period by not more than 6 months, and may adjust the time periods in this paragraph in the case of 
joinder under section 315(c)”). 
 7.  See, e.g., 37 C.F.R. § 42.23 (2016) (explaining that “[a] reply may only respond to argu-
ments raised in the corresponding opposition, patent owner preliminary response, or patent owner 
response.”); id. at § 42.24 (establishing type-volume or page-limits for petitions, motions, opposi-
tions, and replies). 
 8.  35 U.S.C. § 312(a)(3) (2012) (requiring that “the petition identifies, in writing and with 
particularity, each claim challenged, the grounds on which the challenge to each claim is based, and 
the evidence that supports the grounds for the challenge to each claim”); see also id. at § 316(e) (“In 
an inter partes review instituted under this chapter, the petitioner shall have the burden of proving a 
proposition of unpatentability by a preponderance of the evidence.”); 37 C.F.R. §  42.24(a) (2016) 
(setting word limit for petitions). 
 9.  35 U.S.C. § 316 (a)(8) (2012) (providing for the filing by the patent owner of a response to the 
petition under Section 313 after an inter partes review has been instituted, and requiring that the patent 
owner file with such response, through affidavits or declarations, any additional factual evidence and 
expert opinions on which the patent owner relies in support of the response); see also id. at § 316(a)(13) 
(providing the petitioner with at least one opportunity to file written comments within a time period es-
tablished by the Director); 37 C.F.R. § 42.120(a) (2012) (“patent owner may file a response to the petition 
addressing any ground for unpatentability not already denied. A patent owner response is filed as an 
opposition and is subject to the page limits provided in § 42.24”); id. at § 42.24(b)(2) (“The word counts 
for a patent owner response to petition are the same as the word counts for the petition”); id. at § 42.23(b) 
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tive briefing. In fact, the PTAB has generally established that no new evi-
dence may be introduced at the oral hearing and that the parties’ demonstra-
tives must find support in the record, which generally precludes any mean-
ingful response to arguments that have not been addressed previously in the 
proceeding.10 This tightly-controlled process can give rise to APA violations 
when, for example, a petitioner raises new arguments in its reply, but the 
PTAB rules do not guarantee patent owner a sur-reply.11 Similarly, a patent 
owner may raise substantial issues, such as secondary considerations, in its 
response, but petitioner may not be able to respond adequately to those issues 
in its reply given the word-count limits and the need to respond to arguments 
on the merits of the instituted grounds. At present, PTAB practice for han-
dling new arguments is highly variable, with no clear guidance from the 
PTAB or the Federal Circuit on what parties must do to avoid or raise APA 
issues on appeal. 
II. CONTRASTING FEDERAL CIRCUIT DECISIONS ON “NEW 
ARGUMENTS” PRESENTED POST-INSTITUTION 
Recent Federal Circuit cases shed some light on how new arguments 
presented by a party in a patent owner response or in a petitioner’s reply, or 
a new position adopted by the PTAB in the final written decision, may or 
may not violate the APA. In In re NuVasive, Inc., for example, the Federal 
Circuit provided insight into how new arguments presented by a petitioner 
after institution, i.e., arguments not in the petition, can run afoul of the 
APA.12 
In re NuVasive, Inc. involved two companion IPR petitions filed by 
Medtronic against a NuVasive patent.13 Both petitions focused on the obvi-
ousness of certain dimensions for a spinal fusion implant.14 In the first Peti-
tion (IPR2013-00507), Medtronic argued that it would have been obvious to 
 
(“[a] reply may only respond to arguments raised in the corresponding opposition, patent owner prelimi-
nary response, or patent owner response.”); id. at § 42.24(c)(1) (limiting reply to 5,600 words). 
 10.  See Office Patent Trial Practice Guide, 77 Fed. Reg. 48,756, 48,768 (Aug. 14, 2012) (codified 
at 37 C.F.R. pt. 42) (“No new evidence or arguments may be presented at the oral argument.”); see also 
CBS Interactive Inc. v. Helferich Patent Licensing, LLC, IPR2013-00033, Paper 118, at 3 (P.T.A.B. Oct. 
23, 2013) (cautioning that new arguments “would include different characterizations of the evidence and 
different inferences drawn from the evidence. If certain testimony previously was not developed, dis-
cussed, or explained in a party’s papers, it may not be developed, discussed, explained, or summarized, 
for the first time, in the form of demonstrative slides at final oral hearing.”). 
 11.  See infra Part III. 
 12.  841 F.3d 966 (Fed. Cir. 2016). 
 13.  Id. at 967.  
 14.  Id. 
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modify the primary reference in view of a secondary reference, Michelson, 
stating that Michelson teaches the “elongated shape” and “dimensions that 
are longer than wide,” with a citation to a range in Michelson including a 
discussion of its Figure 18.15 In the second Petition (IPR2013-00508), Med-
tronic relied on a different primary reference, modified by Michelson, but 
did not include any assertion about, or citation to, Michelson’s Figure 18.16 
In response to NuVasive’s patent owner responses arguing that no single ref-
erence taught the claimed dimensions, Medtronic pointed to Michelson’s 
Figure 18 in both of its replies. The PTAB denied NuVasive’s request for 
leave to file motions to strike the new argument, or in the alternative, to file 
sur-replies.17 And, at oral argument, the PTAB did not allow NuVasive to 
make substantive arguments in response to Medtronic’s reliance on Figure 
18 of Michelson, and when NuVasive objected to Medtronic’s argument re-
garding Figure 18 during its rebuttal time, the panel “assured NuVasive that 
it understood [its] position and would consider the propriety of Medtronic’s 
arguments when making a final decision.”18 
The Federal Circuit found the notice to NuVasive of Medtronic’s reli-
ance on Figure 18 of Michelson was “minimally sufficient” in IPR2013-
00507, despite the fact that Medtronic did not make a “clear or direct refer-
ence to [the length/width ratio claim] limitation or a clear or direct assertion 
that the [claimed] ratio is shown in Michelson, in Figure 18 or elsewhere.”19 
But in the appeal of IPR2013-00508, the Federal Circuit found that Med-
tronic’s petition did not notify NuVasive of the portions of Michelson that 
later became critical in the proceeding and that the PTAB’s ultimate reliance 
on that material, together with its refusal to allow NuVasive to file a sur-
reply or address the matter during oral argument, amounted to a violation of 
the notice and opportunity to respond provisions of the APA.20 The Federal 
Circuit further noted that although NuVasive was allowed to file “observa-
tions” on the cross-examination of Medtronic’s expert, the “observations” 
were not sufficient to ensure the required opportunity to respond.21 
This case stands in contrast to the Federal Circuit’s decision on the 
PTAB’s handling of claim construction issues in Intellectual Ventures II LLC 
 
 15.  Id. at 969. 
 16.  Id.  
 17.  Id. at 970. 
 18.  Id. 
 19.  Id. at 972. 
 20.  Id. at 972–73.  
 21.  Id. at 973. 
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v. Ericsson Inc.22 There, patent owner Intellectual Ventures argued that its 
procedural due process rights under the APA were violated by the PTAB’s 
adoption of a claim construction in its final written decision that no party 
previously advanced.23 Specifically, Intellectual Ventures contended that 
neither Ericsson nor Google (who filed separate IPR petitions) offered a con-
struction of the term in their respective petitions and that “the Board never 
‘previewed’ its construction until the Google oral argument.”24 
The Federal Circuit disagreed because claim construction of that partic-
ular term was extensively litigated by both parties and the panel questioned 
the parties about the construction at oral hearing.25 Notably, the Federal Cir-
cuit explained that Intellectual Ventures had an opportunity to seek a sur-
reply after it became aware of Google’s and Ericsson’s claim construction 
positions in their respective replies, but it did not do so.26 Nor did Intellectual 
Ventures seek rehearing after the final written decision was issued.27 Based 
on these facts, the Federal Circuit found no violation of the notice and op-
portunity to respond requirements of the APA.28 Presumably, had Intellec-
tual Ventures asked for a sur-reply or a rehearing on the claim construction 
matter, but was denied, and/or the PTAB had not allowed Intellectual Ven-
tures to address the matter during oral hearing, Intellectual Ventures could 
have more plausibly argued under In re NuVasive that there was an APA 
violation. Because claim construction of the term was at issue throughout the 
proceedings, and further because Intellectual Ventures did not seek addi-
tional briefing and was in fact given an opportunity to respond during oral 
arguments, any supposed APA violation resulting from the PTAB’s adoption 
of the new claim construction seemed to have been cured.29 
Similarly, in Genzyme Therapeutic Prods. L.P. v. Biomarin Pharm. 
Inc., patent owner Genzyme argued that the PTAB violated the APA when 
 
 22.  686 F. App’x 900 (Fed. Cir. 2017). 
 23.  Id. at 904–05. 
 24.  Id. 
 25.  Id. at 905. But see Rovalma, S.A., v. Bohler-Edelstahl GMBH & Co. KG, 856 F.3d 1019, 1029 
(Fed. Cir. 2017) (remanding and noting that “although the Board discussed [certain submissions] exten-
sively at the oral argument, that was too late in the absence of an additional adequate opportunity to be 
heard.”). 
 26.  Intellectual Ventures II, 686 F. App’x at 905–06. 
 27.  Id.  
 28.  Id. 
 29.  See id. at 906. 
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it cited references in its final written decisions that were not specifically in-
cluded in the instituted prior art grounds for two IPR proceedings.30 The Fed-
eral Circuit, however, explained that introduction of new evidence during the 
course of the trial was “perfectly permissible under the APA,” as long as 
opposing party is given notice of the evidence and has an opportunity to re-
spond to it.31 Considering the specific facts of the case, the Federal Circuit 
concluded that there was no APA violation because Genzyme had “ample 
notice that the references were in play as potentially relevant evidence” and, 
in fact, had argued against the references in its patent owner responses.32 
III. NEW ARGUMENTS: AN UNSETTLED PTAB PRACTICE 
Thus far, the PTAB has not adopted a standard procedure for enabling 
parties to identify or respond to new arguments introduced following insti-
tution.33 To avail oneself of the argument that the APA has been violated, 
however, a party may have to attempt all avenues to respond.34 In Belden 
Inc. v. Berk-Tek LLC, the Court noted the various processes a patent owner 
may use: 
 
[I]f the petitioner submits a new expert declaration with its 
Reply, the patent owner can respond in multiple ways. It can 
cross-examine the expert and move to file observations on 
the cross-examination. It can move to exclude the declara-
tion. It can dispute the substance of the declaration at oral 
hearing before the Board. It can move for permission to sub-
mit a surreply responding to the declaration’s contents. And 
it can request that the Board waive or suspend a regulation 
that the patent owner believes impairs its opportunity to re-
spond to the declaration. The options are not mutually ex-
clusive.35 
 
 
 30.  825 F.3d 1360, 1366 (Fed. Cir. 2016). 
 31.  Id. 
 32.  Id. at 1367. 
 33.  Belden Inc. v. Berk-Tek LLC., 805 F.3d 1064, 1081 (Fed. Cir. 2015) (noting that “a party 
may cross-examine an affiant who has submitted testimony prepared for review”, “move for additional 
discovery,” “move to exclude evidence” and “‘[i]n the event that cross-examination occurs after a party 
has filed its last substantive paper on an issue . . . [t]he Board may authorize the filing of observations on 
that cross examination, though the observations are to be brief and non-argumentative.”). 
 34.  Id. at 1079. 
 35.  Id. at 1081. 
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Thus, it is up to the parties to identify “new” arguments to the panel and 
seek relief. In Belden, the Court held that the PTAB “provided Belden with 
a meaningful opportunity to respond . . . in that it granted every request 
Belden made for consideration of the issue.”36 However, Belden did not seek 
to file a sur-reply, observations on its cross-examination, or to otherwise 
have the PTAB waive regulations preventing it from responding to a new 
declaration submitted with the petitioners’ reply.37 Therefore, the Court did 
not feel “prepared to find Belden was denied a meaningful opportunity to 
respond.”38 
Our study of PTAB decisions reveals that the opportunity to respond to 
new arguments may be more limited than the Federal Circuit has considered. 
Although the Court commented that a party can make a motion to exclude 
evidence or dispute “the substance . . . at oral hearing before the Board,” the 
PTAB does not generally allow parties to use a motion to exclude or oral 
hearing to present arguments outside of those already in the briefing.39 And 
while the Court cited several cases in which the Board allowed parties to file 
sur-replies to a petitioner’s replies,40 the PTAB’s response to such requests 
for sur-replies has been varied.41 In cases where the patent owner has raised 
 
 36.  Id. at 1082. 
 37.  Id. 
 38.  Id. 
 39. See Office Patent Trial Practice Guide, 77 Fed. Reg. 48,768 (“No new evidence or arguments 
may be presented at the oral argument.”); see also CBS Interactive Inc. v. Helferich Patent Licensing, 
LLC, IPR2013-00033, 2012 WL 9496444, at *3 (cautioning that new arguments “would include different 
characterizations of the evidence and different inferences drawn from the evidence. If certain testimony 
previously was not developed, discussed, or explained in a party’s papers, it may not be developed, dis-
cussed, explained, or summarized, for the first time, in the form of demonstrative slides at final oral 
hearing.”); Apple Inc. v. VOIP-PAL.com, Inc., IPR2016-01201, Paper 43 (P.T.A.B. Dec. 20, 2017) 
(denying motion to expunge but noting “we advise the parties that, to the extent that Patent Owner’s 
Motion to Exclude amounts to an unauthorized sur-reply or seeks to exclude Petitioner’s argument in its 
Reply, such content is not proper for a motion to exclude.”). 
 40.  Belden, 805 F.3d at 1081 (citing Sensio, Inc. v. Select Brands, Inc., IPR2013-00580, 2015 WL 
1009189, at *1, *4–7 (P.T.A.B. Feb. 9, 2015); Zodiac Pool Sys., Inc. v. Aqua Prods., Inc., IPR2013-
00159, 2014 WL 4244016, at *1, *22 (P.T.A.B. Aug. 22, 2014); ABB, Inc. v. ROY–G–BIV Corp., 
IPR2013-00063, 2014 WL 2112556, at *4 (P.T.A.B. May 16, 2014)). 
 41.  See, e.g., Campbell Soup Co. v. Gamon Plus, Inc., IPR2017-00087, IPR2017-00091, IPR2017-
00094, Paper 41, at 3 (P.T.A.B. Nov. 14, 2017) (sur-reply granted); Arris Int’l PLC v. Sony Corp., 
IPR2016-00835, Paper 29 (P.T.A.B. May 26, 2017) (sur-reply granted); Coal. for Afford. Drugs VI, LLC 
v. Celgene Corp., Nos. IPR2015-01092, IPR2013-01096, IPR2015-01102, IPR2015-01103, Paper 65 
(P.T.A.B. Jun. 24, 2016) (sur-reply granted); Instradent USA, Inc. v. Nobel Biocare Servs. AG, IPR2015-
01786, Paper 57 (P.T.A.B. Aug. 16, 2016) (sur-reply granted); ShenZhen Liown Elec. Co., v. Disney 
Enters., Inc., IPR2015-01656, IPR2015-01657, IPR2015-01658, Paper 35 (P.T.A.B. Sept. 2, 2016) (sur-
reply denied); Cisco Sys., Inc. v. TQ Delta, LLC, IPR2016-01007, Paper 20 (P.T.A.B. Jun. 22, 2017) 
(sur-reply denied); Coherus Biosciences Inc. v. AbbVie Biotech. Ltd., IPR2016-00172, IPR2016-00188, 
IPR2016-00189, Paper 46 (P.T.A.B. Jan. 20, 2017) (sur-reply denied); Kranos Corp. v. Riddel, Inc., 
IPR2016-01646, IPR2016-01650, Paper 23 (P.T.A.B. Oct. 16, 2017) (sur-reply denied); Nintendo of Am., 
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secondary considerations, or attempted to swear behind a prior art refer-
ence—issues on which the patent owner bears the ultimate burden of proof—
the Board has allowed a sur-reply so that the patent owner has the “final 
word.”42 But, even in such cases or in cases where a new reference has been 
introduced by the petitioner in its reply, the PTAB has denied reply briefing 
in many instances.43 With many of these denials, the PTAB has taken the 
view that “the Board, sitting as a non-jury tribunal with administrative ex-
pertise, is well positioned to determine and assign appropriate weight to ev-
idence and arguments presented in the briefs, including giving it no weight 
if, for example, the evidence is improperly offered.”44 Instead, the usual 
course taken by the PTAB has been to allow the aggrieved party to submit a 
short paper identifying the location of allegedly new arguments—cautioning 
that the paper should not make any arguments—and allow the responding 
party to submit a paper pointing to the original support.45 
CONCLUSION 
While the process may be uncertain, petitioners and patent owners must 
be vigilant to identify new arguments post-institution to the PTAB and to 
pursue every available remedy including responsive substantive briefing. 
Without such vigilance, a party may find itself unable to make a successful 
APA claim on appeal. In pursuit of a clear and full record, parties should 
memorialize conference calls with the Board, where decisions and arguments 
may otherwise be made off-the-record, by hiring a Court Reporter and filing 
transcripts as exhibits.46 And, as oral hearing transcripts become part of the 
record for appeal, parties may use that opportunity to memorialize what may 
otherwise not be made off-record. Although it has not gained wide ac-
ceptance at the PTAB, some panels may allow an offer of proof under Fed. 
 
Inc. v. Motion Games, LLC, IPR2014-0164, IPR2014-00165, IPR2014-00166, Paper 27 (P.T.A.B. Nov. 
26, 2014) (sur-reply denied). 
 42.  See, e.g., Campbell Soup, Paper 41, at 3 (noting Patent Owner bears the burden of producing 
evidence in the form of secondary considerations of non-obviousness). 
 43.  See, e.g., ShenZhen, Paper 35; Coherus, Paper 46. 
 44.  Kranos, Paper 23. 
 45.  See, e.g., Cisco, Paper 20; Nintendo, Paper 34. 
 46.  See Ultratec, Inc. v. CaptionCall, LLC, 872 F.3d 1267, 1274–75 (Fed. Cir. 2017) (finding no 
burden on the patentee to memorialize the agency reasoning, and noting that the USPTO’s Patent Trial 
Practice Guide and website does not inform parties that they have the right to hire a stenographer to 
transcribe conference calls). 
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R. Civ. P. 103(a)(2)47 to be made by submission or at the Oral Hearing.48 
Finally, in the face of a request for additional briefing by an opponent, parties 
should consider whether to oppose such requests, as a denial may give rise 
to a reversal or remand from the Federal Circuit for an APA violation. 
 
 
 47.  FED. R. EVID. 103(a)(2) (“A party may claim error in a ruling to admit or exclude evidence only 
if the error affects a substantial right of the party and . . . if the ruling excludes evidence, a party informs 
the court of its substance by an offer of proof, unless the substance was apparent from the context.”). 
 48.  See, e.g., Juniper Networks, Inc. v. Chrimar Sys. Inc., IPR2016-01397, Paper 66, at *54, *60 
(P.T.A.B. Dec. 29, 2017) (noting offer of proof submitted at Oral Hearing); Samsung Elec. Co., LTD, v. 
Affinity Labs of Tex., LLC, IPR2014-00209, Paper 51, at *78–80 (P.T.A.B. Apr. 3, 2015) (allowing party 
to make offer of proof at Oral Hearing). But see Int’l Bus. Machs. Corp., v. Intellectual Ventures II LLC, 
IPR2015-01323, Paper 35 (P.T.A.B. Jul. 11, 2016) (denying petitioner’s request for rehearing on denial 
of petitioner’s request for authorization to file offer of proof). 
